Hypoxia has been shown to modulate the expression of immune checkpoints such as CTLA-4, CD47, PD-1/L-1, and TIM3 in order to manipulate immune cells’ mediated anti-tumour response, thereby inhibiting immune surveillance [126]. The gene discussed is PDCD1; the disease is neoplasm.